ITER study of patients with haemophilia A and factor VIII inhibitors

被引：0
|
作者：
Holstein, K. [1 ]
Klamroth, R. [2 ,3 ]
von Depka, M. [4 ]
Gringeri, A. [5 ,6 ]
Lambert, T. [7 ]
Lopez-Fernandez, M. [8 ]
Diniz, M. J. [9 ]
Rocino, A. [10 ]
机构：
[1] Univ Klinikum Hamburg Eppendorf, D-20246 Hamburg, Germany
[2] Vivantes Klinikum Friedrichshain, Innere Med Klin, Berlin, Germany
[3] Vivantes Klinikum Friedrichshain, Hamophiliezentrum, Berlin, Germany
[4] Werlhof Inst, Hannover, Germany
[5] Mangiagalli & Regina Elena Hosp Fdn, IRCCS Maggiore Policlin, A Bianchi Bonomi Hemophilia & Thrombosis Ctr, Milan, Italy
[6] Univ Milan, I-20122 Milan, Italy
[7] Hop Bicetre, AP HP, Ctr Traitement Hemophiles, Le Kremlin Bicetre, France
[8] Complexo Hosp Univ A Coruna, Serv Hematol & Hemotherapia, Thrombosis & Haemostasis Unit, La Coruna, Spain
[9] Hosp San Jose, Ctr Hosp Lisboa Cent, Serv Imuno Hemoterapia, Lisbon, Portugal
[10] San Giovanni Bosco Hosp, Hemophilia & Thrombosis Ctr, Naples, Italy
来源：
HAMOSTASEOLOGIE | 2010年 / 30卷 / 4A期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S46 / S47
页数：2
相关论文
共 50 条
  • [21] Factor VIII inhibitors in patients with congenital severe haemophilia A and its relation to genotype
    Pio, S. F.
    Ozelo, M. C.
    Dos Santos, A.
    De Carvalho, B. V.
    Caram, C.
    Zouain, D.
    Oliveira, G. C.
    Rezende, S. M.
    HAEMOPHILIA, 2012, 18 (06) : e411 - e414
  • [22] Immune tolerance induction in the treatment of paediatric haemophilia A patients with factor VIII inhibitors
    Unuvar, A
    Warrier, I
    Lusher, JM
    HAEMOPHILIA, 2000, 6 (03) : 150 - 157
  • [23] FACTOR-VIII INHIBITORS AND USE OF BLOOD PRODUCTS IN PATIENTS WITH HAEMOPHILIA-A
    IKKALA, E
    SIMONEN, O
    SCANDINAVIAN JOURNAL OF HAEMATOLOGY, 1971, 8 (01): : 16 - &
  • [24] Factor VIII-specific B cell responses in haemophilia A patients with inhibitors
    Van Helden, P. M. W.
    Van Haren, S. D.
    Fijnvandraat, K.
    Van Den Berg, H. Marijke
    Voorberg, J.
    HAEMOPHILIA, 2010, 16 : 35 - 43
  • [25] Thrombin generation in haemophilia A patients with factor VIII inhibitors after infusion of recombinant factor VIIa
    Eichinger, S.
    Lubsczyk, B.
    Kollars, M.
    Traby, L.
    Zwiauer, K.
    Gleiss, A.
    Quehenberger, P.
    Kyrle, P. A.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2009, 39 (08) : 707 - 713
  • [26] Immune tolerance therapy utilizing factor VIII/von Willebrand factor concentrate in haemophilia A patients with high titre factor VIII inhibitors
    Kurth, M. A. H.
    Dimichele, D.
    Sexauer, C.
    Sanders, J. M.
    Torres, M.
    Zappa, S. C.
    Ragni, M.
    Leonard, N.
    HAEMOPHILIA, 2008, 14 (01) : 50 - 55
  • [27] Measurement of recombinant porcine factor VIII in patients with congenital haemophilia A and inhibitors in the presence of emicizumab
    Pfrepper, Christian
    Klamroth, Robert
    Ettingshausen, Carmen Escuriola
    Petros, Sirak
    Siegemund, Annelie
    Siegemund, Thomas
    HAEMOPHILIA, 2024, 30 (02) : 545 - 553
  • [28] Factor VIII inhibitors in previously treated haemophilia a patients with a double virus-inactivated plasma derived factor VIII concentrate
    Peerlinck, K
    Arnout, J
    DiGiambattista, M
    Gilles, JG
    Laub, R
    Jacquemin, M
    SaintRemy, JMR
    Vermylen, J
    THROMBOSIS AND HAEMOSTASIS, 1997, 77 (01) : 80 - 86
  • [29] Factor VIII and IX genotype characterisation of haemophilia patients with transient or permanent inhibitors in Argentina
    Rossetti, L.
    Szurkalo, I.
    Primiani, L.
    Neme, D.
    Candela, M.
    Bianco, R. Perez
    HAEMOPHILIA, 2010, 16 : 77 - 77
  • [30] The prevalence of factor VIII inhibitors and genetic aspects of inhibitor development in Chinese patients with haemophilia A
    Wang, X.
    Yang, R.
    Zhao, Y.
    Wu, J.
    Sun, J.
    Zhang, X.
    HAEMOPHILIA, 2010, 16 : 80 - 80
12345